nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—MAOB—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.112	0.112	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—CRP—osteoarthritis	0.0379	0.0379	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—BGLAP—osteoarthritis	0.0373	0.0373	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—COL10A1—osteoarthritis	0.0361	0.0361	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—FN1—osteoarthritis	0.035	0.035	CbGpPWpGaD
Rasagiline—BCL2—Estrogen signaling pathway—ESR1—osteoarthritis	0.0304	0.0304	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—COMP—osteoarthritis	0.0264	0.0264	CbGpPWpGaD
Rasagiline—CYP1A2—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.0258	0.0258	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—PTGS2—osteoarthritis	0.0254	0.0254	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.0247	0.0247	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—IL1A—osteoarthritis	0.024	0.024	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TNFRSF11B—osteoarthritis	0.0232	0.0232	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—SMAD3—osteoarthritis	0.0222	0.0222	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—MMP1—osteoarthritis	0.0196	0.0196	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—BMP2—osteoarthritis	0.0176	0.0176	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—TNF—osteoarthritis	0.0172	0.0172	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—SMAD3—osteoarthritis	0.0166	0.0166	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—GSTO1—osteoarthritis	0.0161	0.0161	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—IGF1—osteoarthritis	0.0146	0.0146	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—ESR1—osteoarthritis	0.0143	0.0143	CbGpPWpGaD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoarthritis	0.0143	0.0143	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.0142	0.0142	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—IL6—osteoarthritis	0.0138	0.0138	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—COL2A1—osteoarthritis	0.0134	0.0134	CbGpPWpGaD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoarthritis	0.0134	0.0134	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—MMP2—osteoarthritis	0.012	0.012	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—CXCL8—osteoarthritis	0.0116	0.0116	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL1A—osteoarthritis	0.0115	0.0115	CbGpPWpGaD
Rasagiline—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoarthritis	0.0114	0.0114	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—SMAD3—osteoarthritis	0.0111	0.0111	CbGpPWpGaD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—osteoarthritis	0.011	0.011	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—SMAD3—osteoarthritis	0.0107	0.0107	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—CXCL8—osteoarthritis	0.00996	0.00996	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—osteoarthritis	0.00986	0.00986	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—TGFB1—osteoarthritis	0.00939	0.00939	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—IGF1—osteoarthritis	0.00933	0.00933	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—osteoarthritis	0.0091	0.0091	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—FN1—osteoarthritis	0.00891	0.00891	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—TGFB1—osteoarthritis	0.00861	0.00861	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—TNF—osteoarthritis	0.00818	0.00818	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IGF1—osteoarthritis	0.00781	0.00781	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—PTGS2—osteoarthritis	0.00774	0.00774	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.0073	0.0073	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—TNF—osteoarthritis	0.00713	0.00713	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—CXCL8—osteoarthritis	0.00698	0.00698	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.00675	0.00675	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTO1—osteoarthritis	0.00638	0.00638	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—CXCL8—osteoarthritis	0.00628	0.00628	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL1B—osteoarthritis	0.00602	0.00602	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—MMP2—osteoarthritis	0.006	0.006	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—IL6—osteoarthritis	0.00559	0.00559	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00559	0.00559	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—FN1—osteoarthritis	0.00554	0.00554	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CTSK—osteoarthritis	0.0053	0.0053	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—osteoarthritis	0.00522	0.00522	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—TGFB1—osteoarthritis	0.0052	0.0052	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—IGF1—osteoarthritis	0.00486	0.00486	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00484	0.00484	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—FMOD—osteoarthritis	0.0048	0.0048	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TGFB1—osteoarthritis	0.00468	0.00468	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TGFB1—osteoarthritis	0.00454	0.00454	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.00416	0.00416	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00401	0.00401	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGES—osteoarthritis	0.00391	0.00391	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—GSTO1—osteoarthritis	0.00373	0.00373	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—GSTO1—osteoarthritis	0.00368	0.00368	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL6—osteoarthritis	0.00353	0.00353	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—osteoarthritis	0.0032	0.0032	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CAMK2B—osteoarthritis	0.00309	0.00309	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CTSK—osteoarthritis	0.00309	0.00309	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	0.00298	0.00298	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.0029	0.0029	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00279	0.00279	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.00278	0.00278	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTO1—osteoarthritis	0.00276	0.00276	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.00271	0.00271	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—BGN—osteoarthritis	0.00267	0.00267	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CRP—osteoarthritis	0.00247	0.00247	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HSPA5—osteoarthritis	0.00246	0.00246	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1RN—osteoarthritis	0.00239	0.00239	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.00216	0.00216	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00203	0.00203	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.00201	0.00201	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.00201	0.00201	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1A—osteoarthritis	0.00172	0.00172	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CRP—osteoarthritis	0.00144	0.00144	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—FMOD—osteoarthritis	0.00111	0.00111	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGES—osteoarthritis	0.000906	0.000906	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6—osteoarthritis	0.000902	0.000902	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1B—osteoarthritis	0.000898	0.000898	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS2—osteoarthritis	0.000768	0.000768	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTO1—osteoarthritis	0.000638	0.000638	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—BGN—osteoarthritis	0.000618	0.000618	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6—osteoarthritis	0.000526	0.000526	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000399	0.000399	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS2—osteoarthritis	0.000178	0.000178	CbGpPWpGaD
